Is there any predictor for hypersensitivity reactions in gynecologic cancer patients treated with paclitaxel-based therapy?
Aoyama T, Takano M, Miyamoto M, Yoshikawa T, Soyama H, Kato K, Ishibashi H, Iwahashi H, Nakatsuka M, Yajima I, Shimizu Y, Aizawa Y, Suguchi Y, Moriiwa M, Goto T, Sasa H, Nagaoka I, Tsuda H, Furuya K.
Aoyama T, et al. Among authors: iwahashi h.
Cancer Chemother Pharmacol. 2017 Jul;80(1):65-69. doi: 10.1007/s00280-017-3332-7. Epub 2017 May 10.
Cancer Chemother Pharmacol. 2017.
PMID: 28493032